Results 91 to 100 of about 775,328 (297)

Minimal residual disease [PDF]

Bone Marrow Transplantation, 2001
T. Szczepański, J.J.M. van Dongen
  +5 more sources

The therapeutic potential of targeting minimal residual disease in melanoma

Clinical and Translational Medicine, 2023
Background Cutaneous melanoma is a lethal form of skin cancer with morbidity and mortality rates highest amongst European, North American and Australasian populations.
Riyaben P Patel, Pretashini M Somasundram, Lorey K. Smith, Karen E. Sheppard, Grant A. McArthur   +4 more
doaj   +1 more source

High throughput sequencing in acute lymphoblastic leukemia reveals clonal architecture of central nervous system and bone marrow compartments [PDF]

, 2017
No abstract ...
Adams, Stuart, Bartram, Jack, Brooks, Tony, Edwards, Darren, Goulden, Nick, Halsey, Christina, Hubank, Mike, Inglott, Sarah, Wright, Gary, Yousafzai, Yasar   +9 more
core   +3 more sources

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells [PDF]

, 2016
Within the field of cancer research, focus on the study of minimal residual disease (MRD) in the context of carcinoma has grown exponentially over the past several years.
A. Tachtsidis, C. M. Saunders, E. W. Thompson, L. M. McInnes, N. Jacobsen   +4 more
core   +3 more sources

Conformity and controversies in the diagnosis, staging and follow-up evaluation of canine nodal lymphoma: a systematic review of the last 15 years of published literature [PDF]

, 2016
Diagnostic methods used in the initial and post-treatment evaluation of canine lymphoma are heterogeneous and can vary within countries and institutions. Accurate reporting of clinical stage and response assessment is crucial in determining the treatment
D. Stefanello, E. Morello, G. A. Polton, G. Lubas, I. Grant, J. Henriques, L. Marconato, M. Dacasto, null null, O. A. Garden, S. Comazzi, S. Sabattini, T. Hendrickx   +12 more
core   +1 more source

Comparison of next-generation sequencing (NGS) and next-generation flow (NGF) for minimal residual disease (MRD) assessment in multiple myeloma

Blood Cancer Journal, 2020
Detecting persistent minimal residual disease (MRD) allows the identification of patients with an increased risk of relapse and death. In this study, we have evaluated MRD 3 months after transplantation in 106 myeloma patients using a commercial next ...
A. Medina, N. Puig, J. Flores-Montero, C. Jiménez, M. Sarasquete, M. García-Álvarez, Isabel Prieto-Conde, C. Chillon, M. Alcoceba, N. Gutiérrez, A. Oriol, L. Rosiñol, J. Bladé, M. Gironella, M. Hernandez, V. González-Calle, M. Cedena, B. Paiva, J. San-Miguel, J. Lahuerta, M. Mateos, J. Martínez-López, A. Órfão, Marcos González, R. García-Sanz   +24 more
semanticscholar   +1 more source

Strategies for minimal residual disease detection: current perspectives

Blood and Lymphatic Cancer: Targets and Therapy, 2019
Giacomo Andreani, Daniela Cilloni Department of Clinical and Biological Sciences, University of Turin, Turin, Italy Abstract: Currently, the post-remission treatment in acute leukemia is based on the genetic profile of leukemic cells at diagnosis (ie ...
Andreani G, Cilloni D
doaj  

Targeting the 5T4 oncofetal glycoprotein with an antibody drug conjugate (A1mcMMAF) improves survival in patient-derived xenograft models of acute lymphoblastic leukemia

Haematologica, 2017
Outcome in childhood acute lymphoblastic leukemia is prognosticated from levels of minimal residual disease after remission induction therapy. Higher levels of minimal residual disease are associated with inferior results even with intensification of ...
Owen J. McGinn, Shekhar Krishnan, Jean-Pierre Bourquin, Puja Sapra, Clare Dempsey, Vaskar Saha, Peter L. Stern   +6 more
doaj   +1 more source

Clinical Implications of Minimal Residual Disease Detection in Infants With KMT2A-Rearranged Acute Lymphoblastic Leukemia Treated on the Interfant-06 Protocol [PDF]

, 2021
Janine Stutterheim, Inge M. van der Sluis, Paola De Lorenzo, Julia Alten, Philip Ancliffe, Andishe Attarbaschi, Benoît Brethon, Andrea Biondi, Myriam Campbell, Giovanni Cazzaniga, Gabriele Escherich, Alina Ferster, Rishi S. Kotecha, Birgitte Lausen, Chi Kong Li, Luca Lo Nigro, Franco Locatelli, Rolf Marschalek, Claus Meyer, Martin Schrappe, Jan Starý, Ajay Vora, Jan Zuna, Vincent H. J. van der Velden, Tomasz Szczepański, Maria Grazia Valsecchi, Rob Pieters   +26 more
openalex   +1 more source

Outcomes of haploidentical stem cell transplantation for chronic lymphocytic leukemia: a retrospective study on behalf of the chronic malignancies working party of the EBMT [PDF]

, 2017
Allogeneic hematopoietic stem cell transplantation (HCT) may result in long-term disease control in high-risk chronic lymphocytic leukemia (CLL). Recently, haploidentical HCT is gaining interest because of better outcomes with post-transplantation ...
Beelen, Dietrich, Bittenbring, Jörg, Blaise, Didier, Blok, Henric-Jan, Castagna, Luca, Chevallier, Patrice, Ciceri, Fabio, Corradini, Paolo, Eikema, Dirk-Jan, Foá, Roberto, Hallek, Michael, Hilgendorf, Inken, Koc, Yener, Kröger, Nicolaus, Moreno, Carol, Müller, Lutz Peter, Schetelig, Johannes, Selleslag, Dominik, Solano, Carlos, Theobald, Matthias, Tischer, Johanna, van Gelder, Michel, van Gorkom, Gwendolyn, van Lint, M. T.   +23 more
core   +1 more source